Physician profile
Hei Nam C Wong
NPI 1447608872
$561.59
in general payments reported to CMS, 2019-2025
10 companies · $238 in 2025
The $238 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $198 · 2023: $50.58 · 2024: $75.41 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $363.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $201.24 | 2024-2025 | Permeaderm, Cohealyx, Recell |
| Tactile Systems Technology INC | $91.34 | 2022-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Access Pro Medical, LLC | $46.48 | 2022 | |
| Smith+Nephew, INC. | $44.96 | 2022-2025 | Collagenase Santyl |
| Convatec INC. | $40.80 | 2022 | |
| Resmed Corp | $34.41 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $33.65 | 2023 | |
| Urgo Medical North America, LLC | $27.40 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Paratek Pharmaceuticals, INC. | $23.68 | 2025 | Nuzyra |
| Medtronic, INC. | $17.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hei Nam Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.